SMT201500154B - Nuova composizione antifungina - Google Patents

Nuova composizione antifungina

Info

Publication number
SMT201500154B
SMT201500154B SM201500154T SM201500154T SMT201500154B SM T201500154 B SMT201500154 B SM T201500154B SM 201500154 T SM201500154 T SM 201500154T SM 201500154 T SM201500154 T SM 201500154T SM T201500154 B SMT201500154 B SM T201500154B
Authority
SM
San Marino
Prior art keywords
antifungal composition
new antifungal
new
composition
antifungal
Prior art date
Application number
SM201500154T
Other languages
English (en)
Italian (it)
Inventor
Lundahl-Ake
Original Assignee
Moberg Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moberg Pharma Ab filed Critical Moberg Pharma Ab
Publication of SMT201500154B publication Critical patent/SMT201500154B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SM201500154T 2011-02-11 2015-06-30 Nuova composizione antifungina SMT201500154B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1150107 2011-02-11
PCT/EP2012/052327 WO2012107565A1 (fr) 2011-02-11 2012-02-10 Nouvelle composition antifongique

Publications (1)

Publication Number Publication Date
SMT201500154B true SMT201500154B (it) 2015-09-07

Family

ID=45581892

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500154T SMT201500154B (it) 2011-02-11 2015-06-30 Nuova composizione antifungina

Country Status (25)

Country Link
US (3) US8952070B2 (fr)
EP (1) EP2672962B1 (fr)
JP (1) JP5883886B2 (fr)
KR (1) KR101647545B1 (fr)
CN (2) CN103384518B (fr)
AU (1) AU2012215383B2 (fr)
BR (1) BR112013020456B1 (fr)
CA (1) CA2826741C (fr)
CY (1) CY1116275T1 (fr)
DK (1) DK2672962T3 (fr)
ES (1) ES2535827T3 (fr)
HK (1) HK1190944A1 (fr)
HR (1) HRP20150507T1 (fr)
IL (1) IL227765A (fr)
ME (1) ME02152B (fr)
MX (1) MX335945B (fr)
PL (1) PL2672962T3 (fr)
PT (1) PT2672962E (fr)
RS (1) RS53982B1 (fr)
RU (1) RU2587064C2 (fr)
SG (1) SG192615A1 (fr)
SI (1) SI2672962T1 (fr)
SM (1) SMT201500154B (fr)
WO (1) WO2012107565A1 (fr)
ZA (1) ZA201305891B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013020456B1 (pt) 2011-02-11 2020-01-21 Moberg Pharma Ab nova composição antifúngica
EP3151085B1 (fr) * 2012-08-30 2018-07-11 Huawei Device (Dongguan) Co., Ltd. Procédé, appareil et produit logiciel de commande d'unité centrale de traitement
WO2017062761A1 (fr) * 2015-10-07 2017-04-13 Exodos Life Sciences Lp Compositions antifongiques topiques
US10258560B1 (en) 2016-08-08 2019-04-16 Marlinz Pharma, LLC Composition for topical treatment of nail conditions
US10543276B2 (en) 2016-08-08 2020-01-28 Marlinz Pharma, LLC Topical compositions
EP3292758A1 (fr) 2016-09-07 2018-03-14 Rottapharm S.p.A. Composition antimicrobienne comprenant un acide carboxylique et deux diols
EP3784204B1 (fr) * 2018-04-27 2023-12-13 Unigroup ApS Kit pour le champignon des ongles
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
WO2022123228A1 (fr) 2020-12-08 2022-06-16 Moberg Pharma Ab Régime de traitement d'une onychomycose à l'aide de compositions antifongiques d'allylamine

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525635A (en) 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
US6165484A (en) 1997-08-26 2000-12-26 Wake Forest University EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
AUPP146598A0 (en) * 1998-01-21 1998-02-12 Health And Hygiene International Pty Ltd Fruit and vegetable wash
DE19921794A1 (de) 1999-05-11 2000-11-23 Hexal Ag Neue pharmazeutische Zusammensetzung
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
JP4803511B2 (ja) * 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
CN1678277B (zh) * 2002-07-29 2010-05-05 艾克里麦德公司 治疗皮肤病的方法和组合物
BR0313343A (pt) * 2002-09-05 2005-07-12 Galderma Res & Dev Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal
WO2006013963A1 (fr) * 2004-08-05 2006-02-09 Hisamitsu Pharmaceutical Co., Inc. Preparation externe pour les ongles
US20060078599A1 (en) 2004-10-12 2006-04-13 Mathew Ebmeier Pharmaceutical composition applicable to body tissue
JP4992181B2 (ja) 2004-12-28 2012-08-08 大正製薬株式会社 外用剤組成物
WO2006103638A2 (fr) 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Compositions pharmaceutiques topiques de terbinafine et processus de preparation desdites compositions
GB0511499D0 (en) * 2005-06-06 2005-07-13 Medpharm Ltd Topical ungual formulations
CN1939539A (zh) 2005-09-29 2007-04-04 瑞士商拜欧伊果公司 疣、指甲疾病、及指甲保养用之局部配方
KR20080098596A (ko) * 2006-01-02 2008-11-11 티엘티 메디컬 리미티드 조갑 질환 치료용 약학적 조성물
US20070243222A1 (en) * 2006-02-03 2007-10-18 Carl Lawyer Fungicidal formulation and method of use
WO2007094999A2 (fr) * 2006-02-13 2007-08-23 Stiefel Laboratories, Inc. Compositions antifongiques pour les ongles
US20080038219A1 (en) 2006-08-07 2008-02-14 Calgenex Corporation Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
AU2007355106A1 (en) * 2006-11-29 2008-12-18 Foamix Ltd. Foamable waterless compositions with modulating agents
CN101652124A (zh) 2007-02-05 2010-02-17 亲生物有限公司 烯丙胺药物化合物的增加的效力
US20080261986A1 (en) * 2007-03-30 2008-10-23 Friden Phillip M Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
WO2009140215A2 (fr) 2008-05-11 2009-11-19 Geraghty, Erin Procédé pour traiter des infections bactériennes résistant au médicament et d'autres infections par du clioquinol, de la phanquinone et des composés apparentés
MX2011000932A (es) 2008-07-23 2011-05-19 Targeted Delivery Technologies Ltd Metodos para administrar formulaciones antifungicas topicas para el tratamiento de infecciones fungicas.
US8524258B2 (en) * 2008-12-22 2013-09-03 Johnson & Johnson Consumer Companies, Inc. Structured lotions
FR2942716B1 (fr) * 2009-03-06 2011-04-15 Galderma Res & Dev Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle
KR20120038444A (ko) 2009-08-13 2012-04-23 모베르그 데르마 아베 네일의 진균 감염 치료를 위한 조성물 및 방법
CA2785643A1 (fr) * 2009-12-23 2011-06-30 Nuvo Research Inc. Formule de terbinafine hautement permeable
WO2012017371A1 (fr) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi Crème médicinale à base d'acide fusidique fabriquée en utilisant du fusidate de sodium et en incorporant un biopolymère, du propionate de clobétasol, du chlorhydrate de terbinafine et son procédé de fabrication
BR112013020456B1 (pt) 2011-02-11 2020-01-21 Moberg Pharma Ab nova composição antifúngica

Also Published As

Publication number Publication date
RU2587064C2 (ru) 2016-06-10
HRP20150507T1 (hr) 2015-06-19
AU2012215383A1 (en) 2013-08-29
US20170258914A1 (en) 2017-09-14
KR20140025341A (ko) 2014-03-04
SI2672962T1 (sl) 2015-06-30
CA2826741A1 (fr) 2012-08-16
RU2013136147A (ru) 2015-03-20
WO2012107565A1 (fr) 2012-08-16
EP2672962B1 (fr) 2015-03-25
JP5883886B2 (ja) 2016-03-15
US20140031430A1 (en) 2014-01-30
CN103384518B (zh) 2018-10-26
PL2672962T3 (pl) 2015-08-31
HK1190944A1 (en) 2014-07-18
CY1116275T1 (el) 2017-02-08
ES2535827T3 (es) 2015-05-18
DK2672962T3 (en) 2015-04-20
BR112013020456A2 (pt) 2016-10-18
IL227765A0 (en) 2013-09-30
BR112013020456B1 (pt) 2020-01-21
CN109453150A (zh) 2019-03-12
SG192615A1 (en) 2013-09-30
ME02152B (me) 2015-10-20
MX335945B (es) 2016-01-04
RS53982B1 (en) 2015-10-30
US9561279B2 (en) 2017-02-07
US8952070B2 (en) 2015-02-10
MX2013009245A (es) 2013-12-09
JP2014508146A (ja) 2014-04-03
CN103384518A (zh) 2013-11-06
IL227765A (en) 2016-09-29
KR101647545B1 (ko) 2016-08-10
EP2672962A1 (fr) 2013-12-18
PT2672962E (pt) 2015-05-25
ZA201305891B (en) 2015-06-24
US20150250878A1 (en) 2015-09-10
CA2826741C (fr) 2016-03-29
AU2012215383B2 (en) 2016-06-09

Similar Documents

Publication Publication Date Title
CO6980663A2 (es) Composiciones fungicidas
BR112013022112A2 (pt) composição
BR112013022102A2 (pt) composição
DK2686017T3 (da) Oftalmisk sammensætning
BR112014004395A2 (pt) composição
DK2674476T4 (da) Detergentsammensætning
BR112012031667A2 (pt) composição
BR112013017183A2 (pt) composições de bepostatina
BR112014032798A2 (pt) composição
BR112014012016A2 (pt) compostos
BR112012032683A2 (pt) composição
SMT201500154B (it) Nuova composizione antifungina
BR112013033808A2 (pt) composição
CO6870021A2 (es) Conjunto dispensador
PL2680698T3 (pl) Nowe kompozycje grzybobójcze
BR112012032980A2 (pt) composição
CO6842023A2 (es) Composición herbicida
BR112014008067A2 (pt) compostos antibacterianos
CO7010807A2 (es) Dispensador
CO6970601A2 (es) Nueva combinación
BR112014009761A2 (pt) composição oftálmica
BR112013030897A2 (pt) composição.
BR112014032712A2 (pt) composição
BR112014007030A2 (pt) composição
CL2015001192A1 (es) Composición herbicida